And possibly due to a lack of consensus on the association of TRT and prostate cancer risk, PSA was only measured in 76% of patients receiving exogenous hormone (Jasuja, Bhasin, Reisman, Berlowitz, & Rose, 2015). This evidence concerns the gene KLK3 and Familial prostate cancer.